Global Alliance for TB Drug Development Inc

Analysis

Global Alliance for TB Drug Development Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in September 2000, 26 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Global Alliance for TB Drug Development Inc reported income of $60.2m and spending of $55.4m, spending 92% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $174.9m to $60.2m (-66%), an average of -23% a year. The sharpest change came in the year to December 2020, when income dropped by 65%. Over the whole period it spent 73% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Global Alliance for TB Drug Development Inc sits at the 94th percentile: it is larger than about 94% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 98th percentile within NY. Charities of a similar size with the same main cause include Premium Health Inc ($60.2m), Rumford Hospital ($60.3m) and Waupun Memorial Hospital ($60.0m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 83% of the total. Compensation of current officers, directors and key employees was $4.4m (7.9% of expenses). Other salaries and wages came to $9.8m. At year end it held assets of $197.3m against liabilities of $25.6m, net assets of $171.7m. It reported 55 employees.